Furthermore, we highlighted that TSP-1-targeting TAX2 peptide exhibits a unique added value for targeting ovarian cancer (OC) by inhibiting tumor growth, as well as peritoneal dissemination. This evidence concerns the gene THBS1 and ovarian cancer.